EnilloRing 0.12 MG / 0.015 MG per 24HR 3 Week Vaginal System
- RxCUI
- 2644707
- RxNorm name
- EnilloRing 0.12 MG / 0.015 MG per 24HR 3 Week Vaginal System
- Display name
- EnilloRing 0.12 MG / 0.015 MG per 24HR 3 Week Vaginal System
- Full name
- EnilloRing 0.12 MG / 0.015 MG per 24HR 3 Week Vaginal System
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:07
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EnilloRing | ETONOGESTREL AND ETHINYL ESTRADIOL VAGINAL | Xiromed, LLC | 85a126f6-d3e0-9e12-73f9-6176ba36f58b | 2024-06-24 | Boxed warning, Warnings, Adverse reactions | 2644707 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 85a126f6-d3e0-9e12-73f9-6176ba36f58b | EnilloRing 0.12 MG / 0.015 MG per 24HR 3 Week Vaginal System [PSN] · 21 DAY ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System [Enilloring] [SBD] · EnilloRing 0.12/0.015 MG per 24HR 21 Day Vaginal System [SY] | 3 | 2 | These highlights do not include all the information needed to use EnilloRing safely and effectively. See full prescribing information for EnilloRing. EnilloRing® (etonogestrel/ethinyl estradiol vaginal ring) for intravaginal use Initial U.S. Approval: 2001 | 20240624 |